We are live on ! Find out more
AIM

AIM ImmunoTech
AIM

13 hedge funds and large institutions have $3.63M invested in AIM ImmunoTech in 2015 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

0% more funds holding

Funds holding: 13 → 13 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

12% less capital invested

Capital invested by funds: $4.1M → $3.63M (-$475K)

Holders
13
Holders Change
–
Holders Change %
0%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BIT
BlackRock Institutional Trust
California
+$125K
2
Renaissance Technologies
Renaissance Technologies
New York
+$100K
3
AIG
American International Group
New York
+$62.6K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$25K
5
WS
Wedbush Securities
California
+$12.5K

Top Sellers

Rank Fund Capital Flow
1
F
FutureAdvisor
California
-$323K
2
VKH
Virtu KCG Holdings
New York
-$62.6K
3
Morgan Stanley
Morgan Stanley
New York
-$37.5K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$26K
5
JIC
Joel Isaacson & Co
New York
-$4K
Name Holding Trade Value Shares
Change 		Change in
Stake
BIT
1
BlackRock Institutional Trust
California
$1.28M +$125K +10 +10%
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.21M +$25K +2 +2%
OAM
3
Occidental Asset Management
California
$521K – – –
Geode Capital Management
4
Geode Capital Management
Massachusetts
$204K – – –
Renaissance Technologies
5
Renaissance Technologies
New York
$153K +$100K +8 +160%
AIG
6
American International Group
New York
$66.1K +$62.6K +5 New
Northern Trust
7
Northern Trust
Illinois
$53K – – –
Bank of New York Mellon
8
Bank of New York Mellon
New York
$30K – – –
BTS
9
BB&T Securities
Virginia
$29K – – –
State Street
10
State Street
Massachusetts
$18K – – –
WS
11
Wedbush Securities
California
$18K +$12.5K +1 +100%
Morgan Stanley
12
Morgan Stanley
New York
$10K -$37.5K -3 -75%
VKH
13
Virtu KCG Holdings
New York
$9K -$62.6K -5 -83%
GC
14
Guggenheim Capital
Illinois
$9K – – –
Goldman Sachs
15
Goldman Sachs
New York
$6K – – –
UBS Group
16
UBS Group
Switzerland
$5K – – –
DC
17
Davenport & Co
Virginia
$2.28K – – –
BA
18
BlackRock Advisors
Delaware
$2K – – –
ICAS
19
Investors Capital Advisory Services
Massachusetts
$2K – – –
Wells Fargo
20
Wells Fargo
California
$2K – – –
CHC
21
City Holding Co
West Virginia
$1K – – –
Dimensional Fund Advisors
22
Dimensional Fund Advisors
Texas
– -$26K -2 Closed
F
23
FutureAdvisor
California
– -$323K – –
JIC
24
Joel Isaacson & Co
New York
– -$4K – –
NPC
25
National Planning Corporation
California
– -$926 – –

AIM Hedge Fund Activity: Q1 2015 in Review

13 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q1 2015, worth a combined $3.63M — down 12% from $4.1M a quarter earlier.

Fund positioning in AIM was balanced in Q1 2015: 1 fund opened new positions, 1 closed out, 4 added to existing stakes and 2 trimmed.

The largest buyer was BlackRock Institutional Trust, adding an estimated $125K. The largest seller was FutureAdvisor, cutting an estimated $323K.

  • 13 institutional investors held AIM ImmunoTech (AIM) as of Q1 2015, unchanged from Q4 2014.
  • Funds reported $3.63M of AIM ImmunoTech stock for Q1 2015, down 12% quarter-over-quarter.
  • 1 fund opened new AIM ImmunoTech positions in Q1 2015 and 1 closed out, a net change of 0 holders.
  • The largest AIM ImmunoTech buyer in Q1 2015 was BlackRock Institutional Trust, an estimated $125K added.
  • The largest AIM ImmunoTech seller in Q1 2015 was FutureAdvisor, an estimated $323K sold.

Based on aggregated 13F filings for Q1 2015.